Share on StockTwits

Digirad (NASDAQ:DRAD) Director Jeffrey E. Eberwein acquired 10,000 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were purchased at an average price of $3.46 per share, for a total transaction of $34,600.00. Following the purchase, the director now directly owns 40,000 shares of the company’s stock, valued at approximately $138,400. The purchase was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Digirad (NASDAQ:DRAD) traded down 0.57% during mid-day trading on Wednesday, hitting $3.47. 37,737 shares of the company’s stock traded hands. Digirad has a 52 week low of $2.48 and a 52 week high of $4.85. The stock has a 50-day moving average of $3.36 and a 200-day moving average of $3.42. The company has a market cap of $64.5 million and a price-to-earnings ratio of 16.54.

Digirad (NASDAQ:DRAD) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.04 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.03 by $0.01. The company had revenue of $14.60 million for the quarter, compared to the consensus estimate of $12.90 million. On average, analysts predict that Digirad will post $0.09 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Monday, August 25th. Investors of record on Tuesday, August 12th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 5.76%. The ex-dividend date is Friday, August 8th.

Digirad Corporation is the developer and manufacturer of medical diagnostic imaging systems, including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.